Sort
48,018 grants matching “immunotherapy”
Structural biology collaborations
$522,901Susan Lea · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Clinical production of viral vectors for cancer gene therapy
$522,901Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Caspases in Inflammatory Cell Death Networks
$522,895Guy S Salvesen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · GM
Caspases in Inflammatory Cell Death Networks
$522,895Guy S Salvesen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · GM
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
$522,831Arjun Raj · University Of Pennsylvania · R01 · FY2020 · CA
Molecular recognition of proteins by antibodies: A model for rational design
$522,806Sandra Smith-Gill · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$522,753Jessie Villanueva · Wistar Institute · R01 · FY2022 · CA
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer
$522,750David A Mankoff · University Of Pennsylvania · R01 · FY2025 · CA
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy
$522,742Gang Zhou · Augusta University · R01 · FY2025 · CA
Tcf1 programs CD8 T cell responses to enhance viral and cancer immunity
$522,726Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2022 · AI
Research Training in Academic Medical Oncology
$522,717Michael Davies · University Of Tx Md Anderson Can Ctr · T32 · FY2019 · CA
Antibodies, B cells and resistance to human cryptococcosis
$522,712Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Defining a Protective Ebola Vaccine in Non-Human Primates
$522,686Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2018 · AI
Mitochondrial NAD+ in Acute Myeloid Leukemias
$522,539Xiaolu Ang Cambronne · University Of Texas At Austin · R01 · FY2023 · CA
Mitochondrial NAD+ in Acute Myeloid Leukemias
$522,539Xiaolu Ang Cambronne · University Of Texas At Austin · R01 · FY2025 · CA
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
$522,472Robert M. Waymouth · Stanford University · R01 · FY2021 · CA
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
$522,459Yong Wan · Northwestern University At Chicago · R01 · FY2021 · CA
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response
$522,428Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2020 · CA
Intravesical Immunotherapy of Spontaneous Canine Invasive Urothelial Carcinoma
$522,345David Zaharoff · North Carolina State University Raleigh · U01 · FY2023 · CA
Negative Regulation of Osteoclastogenesis
$522,312Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2025 · AR
Tissue Resident memory T cell responses to cancer
$522,276Mary J Turk · Dartmouth College · R01 · FY2022 · CA
Training In Cell and Gene Therapy
$522,265Helen E Heslop · Baylor College Of Medicine · T32 · FY2023 · HL
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT) - DCC
$522,260Susanne May · University Of Washington · U01 · FY2018 · HL
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
$522,238Fotios Asimakopoulos · University Of California, San Diego · R01 · FY2021 · CA
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity
$522,237David C Linehan · University Of Rochester · R01 · FY2021 · CA